Gutierrez-Esteinou Rolando 4
4 · ATAI Life Sciences N.V. · Filed Mar 4, 2022
Insider Transaction Report
Form 4
Gutierrez-Esteinou Rolando
Chief Medical Officer
Transactions
- Award
Stock Option
2022-03-02+206,950→ 206,950 totalExercise: $5.65Exp: 2032-03-01→ Common Shares (206,950 underlying)
Footnotes (1)
- [F1]The stock option vests as to 25% of the underlying shares on March 2, 2023 and as to the remaining underlying shares in 36 substantially equal monthly installments thereafter.